Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03748862 · ClinicalTrials.gov registry record
The Effect of Primary Care Opioid Taper Plans on Sustained Opioid Taper
A clinical trial of Opiate Replacement Therapy, sponsored by Kaiser Permanente.
- Completed
- Registry status
- 2,500
- Enrollment target
- 1
- Study location
NCT03748862: Completed study of Opiate Replacement Therapy, sponsored by Kaiser Permanente.
NCT03748862 is a study of Opiate Replacement Therapy that has completed, run by Kaiser Permanente. The registered enrollment target is 2,500 participants. The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03748862, a study of Opiate Replacement Therapy, has completed, sponsored by Kaiser Permanente.
- COMPLETED
- Registry status
- 2,500 participants
- Enrollment target
- 1
- Study location
Study Summary
The objective of this study is to examine the effects of opioid taper plans as documented in the electronic medical record for Kaiser Permanente Washington (KPWA) patients. The study will compare different types of opioid tapering plans and will report on their effectiveness in producing sustained taper or discontinuation of long-term opioid therapy for chronic non-cancer pain while maintaining adequate pain control. The study population is KPWA patients receiving long-term opioid therapy from 2010 to 2017.
Primary Outcome
First, the study will describe the proportion and characteristics of patients on long-term, high-dose opioid therapy (LtOT) for chronic non-cancer pain who: a) initiate a taper attempt, b) successfully taper, or c) discontinue opioids. Demographic and clinical characteristics of patients who successfully taper will be compared to characteristics of patients who do not. We consider a successful taper to have occurred when a patient's average quarterly morphine milligram equivalents (MME) dose (ca
Conditions Studied
Interventions
- OTHER Taper Plan
Study Locations (1)
Washington
- Kaiser Permanente Washington Health Research Institute - Seattle
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 2,500 participants |
| Start Date | 2018-01-01 |
| Est. Completion | 2019-03-31 |
What the finished NCT03748862 record still lists
NCT03748862 is an observational study that tracks outcomes without assigning an intervention. Its 2,500 participants enrollment target places it among the larger protocols in the corpus.
The record links to 1 condition, with Opiate Replacement Therapy appearing as the primary indexed condition, and to 1 intervention - of which Taper Plan is the first listed.
NCT03748862 reports a single indexed study location in Washington.
Frequently Asked Questions
What is clinical trial NCT03748862 about?
NCT03748862 is a clinical study titled "The Effect of Primary Care Opioid Taper Plans on Sustained Opioid Taper". The objective of this study is to examine the effects of opioid taper plans as documented in the electronic medical record for Kaiser Permanente Washington (KPWA) patients. The study will compare different types of opioid tapering plans and will report on their effectiveness in producing sustained t...
What is the current status of trial NCT03748862?
This trial is currently completed. The enrollment target is 2,500 participants. The study started on 2018-01-01. Estimated completion is 2019-03-31.
What conditions does trial NCT03748862 study?
This clinical trial studies the following conditions: Opiate Replacement Therapy.
What interventions are being tested in trial NCT03748862?
The interventions under investigation include: Taper Plan (OTHER).
Who is sponsoring clinical trial NCT03748862?
This trial is sponsored by Kaiser Permanente, which has 294 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03748862 being conducted?
This trial has 1 study location across Washington. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00001160 · 2,500 participants
Studies on Tumors of the Thyroid
- NCT01904188 · 2,500 participants
Clinical Microbial Species & Antibiotic Resistance ID in ED Patients Presenting With Infection - is Rapid ID Possible & Accurate?
- NCT02257229 · 2,500 participants
Prospective Evaluation of Treatment for Clubfoot
- NCT02530658 · 2,500 participants
Next Generation Sequencing of Normal Tissues Prospectively in Pediatric Oncology Patients
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI